Scientist
Enanta Pharmaceuticals
Rachel Levene, Ph.D. is a scientist at Enanta Pharmacueticals, Inc. She obtained her Ph.D. at Tufts Unversity studying host shutoff in influenza A virus. She now focuses on small molecule antiviral development for RSV and SARS-CoV-2 at Enanta Pharmacueticals, Inc. In her free time she enjoys cooking, going to new restaurants in the Boston are, and running along the Esplanade.